Howmet Aerospace walks into its May 19 earnings with Wall Street freshly bullish — but the stock has pulled back sharply from the highs those same analysts are chasing.
The analyst activity following the company's last earnings is hard to ignore. JP Morgan's Seth Seifman lifted his target to $310 from $265 on May 11, maintaining Overweight. BNP Paribas pushed even higher, raising to $340 from $265, while Susquehanna moved to $330. In aggregate, five firms raised targets after the prior print, clustering in the $290-$340 range against a current price of $260.35. The consensus target of $300 implies roughly 10% upside, though the stock has dropped 4.4% in a single session this week — making the path there look less straightforward than those post-earnings revisions suggested.
Bulls point to Howmet's positioning across structural aerospace demand: gas turbine content and defense exposure give it durable order flow, and EPS momentum ranks in the 86th percentile on a 30-day basis. The company has beaten estimates consistently, ranking in the 81st percentile on EPS surprise. Bears counter that the valuation is demanding at 50x trailing earnings and 34x EV/EBITDA, with a forward EPS growth rank of just 22 — suggesting the market is paying a premium for earnings quality that may already be priced in. The insider picture adds a mild caution note: the Chief Administration Officer sold over $11m of stock on May 11, just days before the print. That follows two earlier tranches in February, totalling around $30m in insider sales over the past 90 days.
The short-selling picture does little to amplify the tension. Short interest has declined roughly 14% over the past month, now at just 2.2% of the float. Availability in the lending market is ample. Cost to borrow is negligible at 0.34%. None of that signals a crowded short thesis — this is not a name where bears are pressing hard heading into the print.
Options positioning has actually eased. The put/call ratio of 1.11 sits below its 20-day average of 1.28, more than one standard deviation lighter on the defensive side. That's a reversal from late April, when the PCR reached 1.57 — its highest reading of the past year. The recent drop suggests some of that hedging demand has unwound as the prior earnings beat reassured options traders. The most recent print produced a 5.5% gain on day one and held a 6.2% move after five days, giving bulls a recent data point in their favour. The print before that, at end of April, delivered a more muted 1.3% day-one reaction but expanded to 15% over the following week.
The May 19 result is therefore a test of whether Howmet can sustain the margin and volume story that has driven five consecutive analyst target increases — at a price that, after this week's pullback, has handed investors a discount relative to where the Street was valuing it just days ago.
See the live data behind this article on ORTEX.
Open HWM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
